Olix Pharmaceuticals, Inc. is based in South Korea. The head office is in Suwon. The enterprise currently operates in the Research and Development in Nanotechnology sector. It was first established on February 26, 2010. It currently has a total number of 69 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 79.98% in Q3C2025. Its total assets grew by 123.15% over the same period. The net profit margin of Olix Pharmaceuticals, Inc. increased by 198.82% in 2025.
Headquarters
1014, 17, Daehak4-Ro, Yeongtong-Gu, Suwon-Si, Gyeonggi-Do
Suwon; Gyeonggi;
Contact Details: Purchase the Olix Pharmaceuticals, Inc. report to view the information.
Website: http://www.olixpharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service